查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1476368

2030 年經腸營養市場預測：按產品、階段、最終用戶和地區分類的全球分析

Enteral Feeding Formulas Market Forecasts to 2030 - Global Analysis By Product, Stage, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球經腸營養市場規模為 58 億美元，預計在預測期內將以 11.7% 的複合年成長率成長，到 2030 年達到 126 億美元。

經腸營養市場包括各種特殊液體營養產品，旨在滿足口服攝取困難人口的營養需求。這些配方奶粉繞過口腔，透過飼管直接進入胃腸道。經腸營養市場迎合各種患者的需求，包括老年人、嚴重患者和殘障人士。

根據 IDF 2021 的數據，大約有 5.37 億成年人患有糖尿病，預計到 2030 年這一數字將增至 6.43 億，到 2045 年將增至 7.83 億。

慢性病增加

癌症、胃腸道疾病和神經病變等疾病的全球流行正在增加對經腸營養解決方案的需求。這些疾病常導致患者吞嚥消化固態食物困難，需要經腸營養等替代餵食方法。經腸營養提供了一種方便有效的方法，繞過口服途徑，將必需的營養素直接輸送到胃腸道。

特殊處方價格昂貴

經腸營養專為滿足患有特定醫療狀況或飲食狀況（例如胃腸道疾病、代謝紊亂或術後恢復）的人群的營養需求而量身定做。然而，這些專用配方的價格高昂，超出了許多患者的經濟承受能力，從而減少了需求並阻礙了市場擴張。然而，醫療機構和保險公司經常面臨預算限制，進一步限制了他們為有需要的患者購買這些昂貴製劑的能力。

營養不良流行病

營養不良是世界普遍存在的問題，由於慢性病、人口老化和飲食攝取不足等因素，影響著各個年齡層的個人。經腸營養提供了一個重要的解決方案，可以直接向無法有效攝取食物或吸收營養的人提供所需的營養。隨著人們對營養在醫療保健中重要性的認知不斷增強，加上醫療技術的進步和醫療成本的不斷上升，對經腸營養的需求不斷增加。

患者缺乏意識且經腸營養報銷不足

許多需要經腸營養支持的患者可能不完全理解適當營養補充的重要性或針對其需求量身定做專門配方的可用性。這種認知的缺乏導致經腸營養產品的利用不足，阻礙了市場的成長。經腸營養的充足報銷是經腸營養市場的主要障礙。經腸營養是口服餵食困難患者醫療照護的重要組成部分，並且高度依賴醫療保健系統和保險提供者的報銷。

COVID-19 的影響：

全球供應鏈中斷導致製造這些配方所需的原料和成分短缺，從而導致生產延誤和供應鏈限制。封鎖措施和對非必要醫療程序的限制導致住院和擇期手術減少，從而導致需要腸道餵食的患者減少。然而，隨著醫療保健系統已經適應了這一流行病並開始處理積壓的延期手術，由於未來病毒浪潮的不確定性以及對醫療保健服務的潛在干擾可能會持續或可能逐漸增加，對經腸營養的需求有所增加。

預計在預測期內，針對特定疾病的牛奶產業將是最大的。

透過滿足患有各種疾病的患者的獨特營養需求，預計特定疾病特異性奶粉在預測期內將成長最快。這些特異性疾病的配方是為了滿足糖尿病、癌症、胃腸道疾病和腎衰竭等疾病患者的獨特飲食需求而配製的。透過提供量身訂製的營養，這些配方可以最佳化患者的治療效果，促進更快的康復，並改善整體醫療保健。

預計長期照護設施領域在預測期內複合年成長率最高

預計長期照護設施產業在預測期內將出現最高的複合年成長率。由於 LTCF 為慢性病患者、殘疾人士或口服餵食有困難的患者提供服務，因此這些設施內對經腸營養的需求始終很高。這些設施通常收容患有吞嚥困難、失智症和中風等疾病的老年人，他們需要個人化的營養支持。因此，LTCF 已成為推動經腸營養開發和創新的重要細分市場，製造商投資研發以滿足該細分市場獨特的營養需求和偏好。

比最大的地區

在估計期間，亞太地區佔據了最大的市場佔有率。由於早產兒的消化器官系統不發達，他們通常需要專門的營養支持，而經腸營養奶粉是他們護理的重要組成部分。隨著早產兒數量的增加，該地區對針對早產兒獨特需求量身定做的高品質、營養豐富的經腸營養的需求不斷成長。需求的激增導致醫療保健提供者和設施大量採購經腸營養，從而推動了區域成長。

複合年成長率最高的地區：

預計歐洲地區在預測期內將保持盈利成長。歐洲食品安全局 (EFSA) 和歐洲藥品管理局 (EMA) 等嚴格的法規結構為經腸營養的製造、標籤和分銷制定了標準。這些法規要求進行徹底的測試、成分透明度以及遵守特定的營養指南。此外，歐洲政府對經腸營養實施的報銷政策透過促進有需要的患者獲得產品進一步刺激市場成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球經腸營養市場：依產品

  • 標準型
  • 按病種開藥
    • 阿茲海默症
    • 癌症治療
    • 吸收不良
    • 糖尿病
    • 罕見疾病
    • 慢性腎臟病
  • 其他產品

第6章全球經腸營養市場：依階段

  • 兒童
  • 成人

第7章全球經腸營養市場：依最終用戶分類

  • 醫院
  • 居家照護
  • 長期照護設施
  • 其他最終用戶

第8章全球經腸營養市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • Danone SA
  • Primus Pharmaceuticals, Inc
  • Fresenius Kabi AG
  • Meiji Holdings. Co., Ltd
  • Abbott
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Nestle
  • B. Braun Melsungen AG
  • Nutritional Medicinals, LLC
  • Medtrition Inc
  • DermaRite Industries, LLC
Product Code: SMRC25914

According to Stratistics MRC, the Global Enteral Feeding Formulas Market is accounted for $5.8 billion in 2023 and is expected to reach $12.6 billion by 2030 growing at a CAGR of 11.7% during the forecast period. The enteral feeding formulas market encompasses a range of specialized liquid nutrition products designed to meet the nutritional needs of individuals who are unable to consume food orally. These formulas are administered directly into the gastrointestinal tract through feeding tubes, bypassing the oral cavity. The enteral feeding formulas market serves a diverse range of patients, including the elderly, critically ill, and individuals with disabilities.

According to the IDF 2021, approximately 537 million adults are living with diabetes, and the number of people adults living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

As conditions such as cancer, gastrointestinal disorders, and neurological disorders become more prevalent globally, the demand for enteral nutrition solutions rises. These conditions often result in patients experiencing difficulty in swallowing or digesting solid food, necessitating alternative feeding methods like enteral nutrition. Enteral feeding formulas offer a convenient and effective way to deliver essential nutrients directly into the gastrointestinal tract, bypassing the oral route.

Restraint:

High cost of specialized formulas

These formulas are tailored to meet the nutritional needs of individuals with specific medical conditions or dietary requirements, such as those with gastrointestinal disorders, metabolic diseases, or recovering from surgery. However, the exorbitant prices of these specialized formulas make them financially inaccessible to many patients, leading to decreased demand and hindering market expansion. However, healthcare facilities and insurers often face budget constraints, further limiting their ability to procure these costly formulas for patients in need.

Opportunity:

Growing prevalence of malnutrition

Malnutrition is a widespread issue globally, affecting individuals across various age groups due to factors such as chronic illnesses, aging populations, and inadequate dietary intake. Enteral feeding formulas provide a crucial solution for delivering essential nutrients directly to individuals who are unable to consume food orally or absorb nutrients effectively. With the rising awareness about the importance of nutrition in healthcare, coupled with advancements in medical technology and increasing healthcare expenditure, the demand for enteral feeding formulas is on the rise.

Threat:

Lack of patient awareness and insufficient reimbursements for enteral nutrition

Many individuals requiring enteral nutrition support may not fully understand the importance of proper nutrition or the availability of specialized formulas tailored to their needs. This lack of awareness leads to underutilization of enteral feeding products, thereby hindering market growth. Insufficient reimbursements for enteral nutrition are significantly hindering the Enteral Feeding Formulas Market. Enteral nutrition, a critical component of medical care for individuals unable to consume food orally, relies heavily on reimbursements from healthcare systems or insurance providers.

Covid-19 Impact:

Disruptions in the global supply chain led to shortages of raw materials and ingredients essential for manufacturing these formulas, resulting in production delays and supply chain constraints. Lockdown measures and restrictions on non-essential medical procedures reduced hospital admissions and elective surgeries, leading to a decline in the number of patients requiring enteral nutrition support. However, as healthcare systems adapted to the pandemic and began to address the backlog of postponed procedures, the demand for enteral feeding formulas may have gradually rebounded, albeit with ongoing uncertainties regarding future waves of the virus and potential disruptions to healthcare services.

The Disease-specific Formula segment is expected to be the largest during the forecast period

Disease-specific Formula segment is expected to be the largest during the forecast period by catering to the specific nutritional needs of patients with various medical conditions. These specialized formulas are formulated to address the unique dietary requirements of individuals suffering from diseases such as diabetes, cancer, gastrointestinal disorders, and renal failure, among others. By providing tailored nutrition, these formulas optimize patient outcomes, promote faster recovery, and improve overall health management.

The Long Term Care Facilities segment is expected to have the highest CAGR during the forecast period

Long Term Care Facilities segment is expected to have the highest CAGR during the forecast period. As LTCFs cater to individuals with chronic illnesses, disabilities, or those who are unable to consume food orally, the demand for enteral feeding formulas within these facilities is consistently high. These facilities often house elderly individuals with conditions such as dysphagia, dementia, or stroke, who require tailored nutritional support. Consequently, LTCFs represent a crucial market segment driving the development and innovation of enteral feeding formulas, prompting manufacturers to invest in research and development to meet the specific nutritional needs and preferences of this demographic.

Region with largest share:

Asia Pacific region commanded the largest share of the market over the extrapolated period. Preterm infants often require specialized nutritional support due to their underdeveloped gastrointestinal systems, making enteral feeding formulas a vital component of their care. With an increasing number of preterm births, there's a growing demand for high-quality, nutrient-rich enteral feeding formulas tailored to the unique needs of premature infants in the region. This surge in demand has prompted healthcare providers and facilities to procure a greater volume of enteral feeding formulas, thereby driving regional growth.

Region with highest CAGR:

Europe region is poised to hold profitable growth during the forecast period. Stringent regulatory frameworks such as the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) set standards for the production, labeling, and distribution of enteral feeding formulas. These regulations mandate thorough testing, ingredient transparency, and adherence to specific nutritional guidelines. Moreover, reimbursement policies implemented by European governments for enteral nutrition products further stimulate market growth by facilitating access for patients in need.

Key players in the market

Some of the key players in Enteral Feeding Formulas market include Danone S.A, Primus Pharmaceuticals, Inc, Fresenius Kabi AG, Meiji Holdings. Co., Ltd, Abbott, Hormel Foods Corporation, Mead Johnson & Company, LLC, Nestle, B. Braun Melsungen AG, Nutritional Medicinals, LLC, Medtrition Inc and DermaRite Industries, LLC.

Key Developments:

In September 2023, Abbott announced the plan to boost manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.

In February 2023, Nestle and EraCal Therapeutics initiated a research collaboration to identify novel nutraceuticals for controlling food intake

In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste.

In September 2022, Kate Farms raised USD 75 million in a Series C funding round led by life-science investor Novo Holdings. With this, Kate Farms will be able to increase its efforts in developing plant-based clinical nutrition research, product innovation, and development into more channels.

Products Covered:

  • Standard Formula
  • Disease-specific Formula
  • Other Products

Stages Covered:

  • Pediatric
  • Adult

End Users Covered:

  • Hospitals
  • Home Care
  • Long Term Care Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Enteral Feeding Formulas Market, By Product

  • 5.1 Introduction
  • 5.2 Standard Formula
  • 5.3 Disease-specific Formula
    • 5.3.1 Alzheimer's Disease
    • 5.3.2 Cancer Care
    • 5.3.3 Malabsorption
    • 5.3.4 Diabetes
    • 5.3.5 Orphan Diseases
    • 5.3.6 Chronic Kidney Diseases
  • 5.4 Other Products

6 Global Enteral Feeding Formulas Market, By Stage

  • 6.1 Introduction
  • 6.2 Pediatric
  • 6.3 Adult

7 Global Enteral Feeding Formulas Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Home Care
  • 7.4 Long Term Care Facilities
  • 7.5 Other End Users

8 Global Enteral Feeding Formulas Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Danone S.A
  • 10.2 Primus Pharmaceuticals, Inc
  • 10.3 Fresenius Kabi AG
  • 10.4 Meiji Holdings. Co., Ltd
  • 10.5 Abbott
  • 10.6 Hormel Foods Corporation
  • 10.7 Mead Johnson & Company, LLC
  • 10.8 Nestle
  • 10.9 B. Braun Melsungen AG
  • 10.10 Nutritional Medicinals, LLC
  • 10.11 Medtrition Inc
  • 10.12 DermaRite Industries, LLC

List of Tables

  • Table 1 Global Enteral Feeding Formulas Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 4 Global Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 5 Global Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 6 Global Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 7 Global Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 8 Global Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 9 Global Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 10 Global Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 11 Global Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 13 Global Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 14 Global Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 15 Global Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 16 Global Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 17 Global Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 18 Global Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 19 Global Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 20 North America Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 22 North America Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 23 North America Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 24 North America Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 25 North America Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 26 North America Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 27 North America Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 28 North America Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 29 North America Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 30 North America Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 31 North America Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 32 North America Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 33 North America Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 34 North America Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 North America Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 North America Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 37 North America Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 38 North America Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 39 Europe Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 41 Europe Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 42 Europe Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 43 Europe Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 44 Europe Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 45 Europe Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 46 Europe Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 47 Europe Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 48 Europe Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 49 Europe Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 50 Europe Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 51 Europe Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 52 Europe Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 53 Europe Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 54 Europe Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 55 Europe Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 56 Europe Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 57 Europe Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 58 Asia Pacific Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 60 Asia Pacific Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 61 Asia Pacific Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 62 Asia Pacific Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 63 Asia Pacific Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 64 Asia Pacific Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 65 Asia Pacific Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 66 Asia Pacific Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 67 Asia Pacific Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 68 Asia Pacific Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 69 Asia Pacific Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 70 Asia Pacific Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 71 Asia Pacific Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 72 Asia Pacific Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 73 Asia Pacific Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 74 Asia Pacific Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 75 Asia Pacific Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 76 Asia Pacific Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 77 South America Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 79 South America Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 80 South America Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 81 South America Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 82 South America Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 83 South America Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 84 South America Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 85 South America Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 86 South America Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 87 South America Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 88 South America Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 89 South America Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 90 South America Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 91 South America Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 92 South America Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 93 South America Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 94 South America Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 95 South America Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 96 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 98 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 99 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 100 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 101 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 102 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 103 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 104 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 105 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 106 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 107 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 108 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 109 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 110 Middle East & Africa Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 112 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 113 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 114 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)